About

Pancreatic cancer is usually detected at late stages, meaning that most patients die within one year after diagnosis.

PANCAID, acronym for PANcreatic CAncer Initial Detection via liquid biopsy, is an international research consortium aiming to provide a minimally invasive blood test using a comprehensive panel of liquid biopsy diagnostics for the early detection of pancreatic cancer.

The research project, which will receive funding of a total of EUR 9.8M from the European Commission (EC), commenced its work in January 2023.

For more information, visit www.pancaid-project.eu.
Follow the PANCAID project on Twitter (@PANCAID_EU) and LinkedIn.